Program
Invited Speakers
President-Elect, CINP
Presentation Title: Inositol, Lithium and Depression.
President, Malaysian Psychiatric Association
Presentation Title: Drug substitution treatment for heroin addiction in Malaysia: From policy conflict to upscaling plan.
Past-President, CINP
Presentation Title: The end of the amine hypothesis of depression: is it time for a celebration?
The University of New South Wales
Presentation Title: The emerging genetics of the mood disorders: Implications for therapy.
President, CINP 2006 - 2008
Presentation Title: Novel leads in the treatment of schizophrenia with focus on cognitive deficits and negative symptoms.
Osaka University
Presentation Title: Development of drugs for alzheimer and neurodegenerative disorders.
University of Hong Kong
Presentation Title: Missing gaps in antidepressant drug development.
Ashiya University
Presentation Title: Impact of sensitization in behavioral sensitization, spontaneous recurrence of methamphetamine psychosis and schizophrenia.
Inje University
Presentation Title: Mechanisms of neuroprotective action of atypical antipsychotic drugs.
CINP Education Symposium
Date: Tuesday, 4 March 2008
Time: 08:30 - 12:00
Cost: No charge. Attendance only available to full registrants.
Chairperson: Professor Brian Leonard
This workshop is designed particularly for researchers who want to update their skills in Psychopharmacological Research Approaches, young researchers commencing trials or research.
It will include presentations and participation by Brian Leonard (Ireland), Angelos Halaris (USA), Brian Dean (Australia) and Amir Kalali (USA).
Professor Robert Belmaker
Dr. Belmaker, Professor of Psychiatry at Ben Gurion University, Beersheva, Israel, has received the Anna Monika Prize for Research in Depression (1983), the Ziskind-Somerfeld Prize for Senior Research in Psychiatry (1993), the European College of Neuropsychopharmacology Lilly Research Award (1996), the National Alliance for Research on Schizophrenia and Depression Lifetime Achievement Falcone Award for research in affective disorder (2000) and the Research Prize of the World Federation of Societies of Biological Psychiatry (2004). Since 1998 he has been Associate Editor of Bipolar Disorders. He is President Elect of the CINP (International College of Neuropsychopharmacology).
Professor Brian Leonard
Professor Brian Leonard is the Past President of the CINP and maintains an active research group at the University of Maastricht in The Netherlands. His current major research interest is in the role of immune processes and cytokines in depression and dementia. In a research career spanning more than 35 years Professor Leonard has both industrial experience as well as a long standing academic career. He has supervised numerous MSc, PhD and MD candidates in the area of stress, anxiety and depression. His seminal textbook Fundamentals of Psychopharmacology now in its third edition provides one of the most lucid explanations of the field for both undergraduate and postgraduate students available.
Professor Mohamad Hussain Bin Habil MMBS MPM DAB
Professor Dr Hussain Bin Habil is a Professor of Psychological Medicine of the University of Malaya. He completed his medical degree (MBBS) and Masters of Psychological Medicine at the University of Malaya and his Diploma of Addictive Behaviour at the University of London. Professor Hussain has developed special interests and expertise in addictions and addictive behaviours. He has been the WHO representative for Malaysia. He has presented at a wide range of national, regional and international meetings. Professor Hussain has been involved in over 13 clinical trials of anti-depressant and anti-psychotic medications for a wide variety of pharmaceutical companies. He is a major innovator and opinion leader in Malaysian, Asian and International Psychiatry. He is currently the President of the Malaysian Psychiatric Association.
Professor Philip Mitchell
Philip Mitchell MB BS, MD, FRANZCP, FRCPsych is Professor and Head of the School of Psychiatry at the University of New South Wales; Convenor of Brain Sciences UNSW; Chair of the NSW Mental Health Priority Taskforce; Consultant Psychiatrist, Prince of Wales Hospital, and Black Dog Institute, Sydney; Guest Professor, Shanghai Jaiotong University; and Board Member of the Anika Foundation.
His research and clinical interests are in bipolar disorder and depression, with a particular focus on the molecular genetics of bipolar disorder, transcranial magnetic stimulation (TMS) for depression, and the pharmacological and psychological treatment of bipolar disorder and depression.
Professor Mitchell has published (in conjunction with colleagues) over 400 papers or chapters on these topics and is a member of an NHMRC-funded Program Grant on depression and bipolar disorder. He is an assistant editor of the 'Australian and New Zealand Journal of Psychiatry' and also serves on the editorial boards of 'Psychiatric Genetics', 'CNS Drugs', 'Current Therapeutic Research' and 'Medicine Today' .
In 2002 Prof. Mitchell was awarded the Senior Research Award of the Royal Australian and New Zealand College of Psychiatrists. In 2004, he received the Founders Medal of the Australasian Society for Psychiatry Research. In 2006, he received a Medical Media award from Research Australia for his media commentary on a wide range of mental health issues.
Professor Mitchell also serves on the NSW Health Care Advisory Council.
Professor Torgny H. Svensson
Presentation Title: Novel leads in the treatment of schizophrenia with focus on cognitive deficits and negative symptoms.
Dr. Svensson, M.D., Ph.D., is professor of pharmacology and a member of the Nobel Assembly at the Karolinska Institutet in Stockholm, Sweden. He received his basic scientific training with Arvid Carlsson, George Aghajanian and Floyd Bloom, and has published around 290 papers and many patent applications. His major contributions concern the mode of action of antipsychotic and antidepressant drugs, as well as the development of various augmentation strategies, and he has in addition generated important leads to the understanding and treatment of nicotine dependence. He has been an invited speaker at innumerous international meetings and serves as an advisor to several academic research institutions as well as drug companies. Dr. Svensson has received many awards and honors, among them the European College of Neuropsychopharmacology Lilly Neuroscience, Basic Science Award in 2000. In 1997 he founded Independent Pharmaceutica, which develops an immunologically based treatment of nicotine dependence. Dr. Svensson served as President of the Scandinavian College of Neuro-Psychopharmacology 2001-2005 and is currently President of the Collegium Internationale Neuro-Psychopharmacologicum.
Professor Masatoshi Takeda
Professor Masatoshi Takeda, MD, PhD, has been the chairman professor of the Department of Psychiatry, Osaka University Graduate School of Medicine for more than ten years. With his background of neurochemistry, molecular genetics, and cell biology, his research interest covers topics in psychogeriatrics, and cognitive impairment in psychiatric disorders. He has published over 250 original papers in English, and over 300 review papers.
Professor Takeda is a Board Member of the Japanese Society of Psychiatry & Neurology, Japanese Society of Biological Psychiatry, Japanese Society of Dementia Research, Japanese Psychogeriatric Society, and Japanese Society of Neurochemistry. He is the Editor-in-Chief of the Japanese Journal of Psychiatry and Neurology, Psychogeriatrics, Cognition and Dementia, Schizophrenia Frontier.
Professor SW Tang
Professor SW Tang is Emeritus Professor and former Chair of Psychiatry at the University of California, Irvine and is Chair Professor of Psychiatry at the University of Hong Kong. Professor Tang graduated from the University of Hong Kong Medical School in 1971, after which he trained at the Clarke Institute of Psychiatry, University of Toronto and obtained his specialist qualification in both Canada and the USA. Interested in research, he attended the Institute of Medical Sciences at the University of Toronto and obtained his PhD in neurochemistry. On a MRC fellowship, he spent a postdoctoral year in dopamine and serotonin receptor research at the Department of Pharmacology, University of Toronto, under Professor Philip Seeman, the discoverer of brain dopamine receptor changes in schizophrenia. Professor Tang's research work on serotonin receptors contributed significantly to the development of a new generation of atypical neuroleptics and SSRI antidepressants. After heading the Psychopharmacology department at the Clarke Institute (succeeding Professor Hornykiewizc, who discovered dopamine deficiency in Parkinsonˇ¦s disease), Professor Tang was recruited to the University of California, Irvine. Subsequently, he successfully restructured the psychiatry department at the Long Beach VA Hospital (a primary teaching hospital for the University of California Medical School) in the most challenging Southern California managed care environment. He was later selected as Professor and Chairman by the University of California, becoming the first and only Chair of Psychiatry of Chinese origin in the USA. His primary research and academic interests include mood disorders, drug discovery and clinical and molecular psychopharmacology. In addition he is also an MBA (UCLA) and was trained in computer sciences and information technology. He has great interests in biological and medical aspects of psychiatry, healthcare restructuring, research in managerial and organizational behavior and application of IT in medicine.
Professor Kunio Yui
Professor Kunio Yui is Professor, Research Institute of Asperger Disorder, Ashiya University, Japan and visiting professor at both the Kansai University of International Studies and the Department of Psychiatry and Neurology, Kobe University. He graduated MD from Juntendo University (Tokyo) in 1967 and Ph.D. in 1987 from, Hirosaki University, Japan. His Psychiatry training was at the Jichi Medical School, Japan. He has published and presented extensively particularly in the area of neurobiological mechanisms for methamphetamine induced psychoses and the relevance of this research for schizophrenia.
Professor Young-Hoon Kim
Professor Young-Hoon Kim is Professor of Psychiatry at School of Medicine and former Director of Paik Institute for Clinical Research, Inje University, Busan, South Korea. He has been a major opinion leader in the field of neurobiology and psychopharmacology in Korea and the President of Korean College of Neuropsychopharmacology (2005~present). He graduated from Seoul National University in 1978 and received Ph.D. in Neurochemistry in 1992 from Inje University in Busan. He had research experiences in neuroscience at Kyoto Prefectural University, Japan (1990) and Pohang University of Science and Technology, Korea (1996). His current major research interest is in the mechanisms of neuroprotective action of atypical antipsychotic drugs against toxic models such as serum deprivation and MPP+ toxicity in cultured neuronal cells. Another research interest in clinical field is to investigate the effects of cholinergic and glutamatergic drugs for the improvement in cognition of patients with schizophrenia.